摘要
目的探讨凝血酶增高大鼠的小脑颗粒细胞N-甲基-D-天冬氨酸受体(NMDA)敏感性是否与细胞内组织型谷氨酰胺转移酶(tTG)变化有关.方法以0.01 U/ml浓度凝血酶单独或与tTG抑制剂单丹磺酰尸胺(MDC) 0.5×10-4 mol/L处理原代培养的Wistar大鼠小脑颗粒细胞30 min后,以0.1×10-4 mol/L、0.25×10-4 mol/L和0.5×10-4 mol/L 3种浓度NMDA作用3 h诱导上述处理的细胞凋亡,比较流式细胞仪检测到的细胞凋亡率差异以判断NMDA受体敏感性的变化;RT-PCR和Gelpro图像分析软件检测各NMDA浓度有/无凝血酶预处理的细胞内tTG mRNA变化差异.结果凝血酶预处理细胞后上述3种浓度NMDA诱导的细胞凋亡率均升高[(8.3±0.5~15.1±0.8)%, (14.1±1.1~23.8±0.7)%, (26.8±1.9~33.7±2.1)%].预处理细胞时加入MDC可阻断凝血酶对NMDA受体的这种影响,细胞凋亡率降至(5.8±1.2)%、(11.5±1.5)%和(19.0±1.7)%;凝血酶预处理后各浓度NMDA处理细胞内tTG mRNA量均同一浓度单独NMDA处理的细胞高.结论凝血酶通过增高细胞内tTG使小脑颗粒细胞NMDA受体敏感性增高.
Objective To explore the possible relationship between the thrombin induced potentiation of rat cerebellum granular cell N-methyl-D-aspartate (NMDA) receptor function and the change of intracellular tissue transglutaminase (tTG). Methods Primary cultured rat cerebellum granular cells were pretreated by using thrombin (0. 01 U/ml) with or without co-pretreatement of 0. 5 × 10^-4 mol/L MDC (monodansylcadaverine, a tTG inhibitor) 30 minutes. Induce cells mentioned above to undergo apoptosis with different concentration of NMDA (0. 1 × 10^-4 tool/L,0. 25 × 10^-4mol/L and 0. 5 × 10^-4 mol/L) . Flowcytometer was applied 3 hours later to detect the changed function of NMDA receptor by counting percentage of apoptotic cells. RT-PCR was used to compare the tTG mRNA level in the cerebellum granular cells treated with NMDA of same dosage with/without thrombin pretreatment. Results Thrombin pretreatment increased the percentage of apoptosis cells induced by NMDA [ ( 8. 3 ± 0.5 ) % to ( 15. 1 ± 0.8)% at0. 1 xl0-4 mol/L,(14. 1 ±1.1)% to (23.8±0.7)% at 0.25×10^-4 mol/L, (26.821.9)% to (33.7 22. 1)% at 0.5 × 10^-4 mol/L) ] ; and this effect was inhibited by co-pretreatment MDC with thrombin, cell apoptosis decreased to ( 5. 8±1.2 ) %, ( 11.5±1.5 ) % and ( 19. 0±1.7 ) % ; Thrombin increased intracellular tTG mRNA levels comparing with those without thrombin pretreatment. Conclusion Thrombin potentiates rat cerebellum granular cell NMDA receptor function by increasing intracellular tissue transglutaminase.
出处
《中华内科杂志》
CAS
CSCD
北大核心
2005年第9期668-671,共4页
Chinese Journal of Internal Medicine